Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.

Launched by CASA DI CURA IGEA · Nov 20, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving how we assess cognitive decline and memory issues in older adults. Researchers are working to translate and adapt specific questionnaires and scales that help evaluate daily functioning and behaviors in people with different levels of cognitive impairment, like Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), and mild dementia. The goal is to ensure these tools are available in Italian and to test how reliable and valid they are for identifying these conditions.

To participate in this study, individuals must be at least 60 years old and have a caregiver who can provide insights about their daily functioning. Participants will fill out the translated questionnaires and may undergo some cognitive tests. The study is currently recruiting, and it's an opportunity for those experiencing memory issues or their caregivers to contribute to important research that could improve diagnosis and care for cognitive decline in Italy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 60 years;
• • Availability of an informant/caregiver, able to judge their functional abilities.
• For neurologically unimpaired elderly:
• • - Normal performance on the Mini Mental State Examination (Folstein et al. 1975; Foderaro et al., 2022).
• For clinical groups: Conditions consistent with:
• • Subjective Cognitive Decline (Jessen et al., 2014)
• • Mild Cognitive Impairment (Winblad et al., 2004)
• • Mild Major Neurocognitive Disorder according (DSM-5-TR, APA, 2022).
• Exclusion Criteria:
• • Refusal or inability to sign informed consent;
• • For the clinical groups: other neurological or psychiatric conditions that may explain the presence of cognitive difficulties.